{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:01:37Z","timestamp":1782986497658,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.annepidem.2019.12.011","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T05:34:44Z","timestamp":1578375284000},"page":"50-57.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Epidemiology of pediatric buprenorphine and methadone exposures reported to the poison centers"],"prefix":"10.1016","volume":"42","author":[{"given":"Saumitra V.","family":"Rege","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc Anh","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassima","family":"Ait-Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Rizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Holstege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.annepidem.2019.12.011_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2013.272","article-title":"Pharmaceutical overdose deaths, United States, 2010","volume":"309","author":"Jones","year":"2013","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.annepidem.2019.12.011_bib3","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2013tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.annepidem.2019.12.011_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v26n03_12","article-title":"Abuse of buprenorphine in the United States: 2003-2005","volume":"26","author":"Smith","year":"2007","journal-title":"J\u00a0Addict Dis"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.011_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2014.02.003","article-title":"Abuse and diversion of buprenorphine sublingual tablets and film","volume":"47","author":"Lavonas","year":"2014","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"Suppl 1","key":"10.1016\/j.annepidem.2019.12.011_bib6","first-page":"S42","article-title":"Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience","volume":"13","author":"Amass","year":"2004","journal-title":"Am J Addict"},{"key":"10.1016\/j.annepidem.2019.12.011_bib7","series-title":"Emergency department visits involving buprenorphine","author":"Crane","year":"2013"},{"issue":"5","key":"10.1016\/j.annepidem.2019.12.011_bib9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jpeds.2013.06.058","article-title":"Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children","volume":"163","author":"Lavonas","year":"2013","journal-title":"J\u00a0Pediatr"},{"issue":"2S","key":"10.1016\/j.annepidem.2019.12.011_bib10","doi-asserted-by":"crossref","first-page":"s83","DOI":"10.1016\/j.japh.2017.01.015","article-title":"Unintentional methadone and buprenorphine exposures in children: developing prevention messages","volume":"57","author":"Schwartz","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"6","key":"10.1016\/j.annepidem.2019.12.011_bib11","doi-asserted-by":"crossref","first-page":"e1597","DOI":"10.1542\/peds.2011-0926","article-title":"Preventing medication overdoses in young children: an opportunity for harm elimination","volume":"127","author":"Budnitz","year":"2011","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.annepidem.2019.12.011_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amepre.2009.05.018","article-title":"Medication overdoses leading to emergency department visits among children","volume":"37","author":"Schillie","year":"2009","journal-title":"Am J Prev Med"},{"issue":"41","key":"10.1016\/j.annepidem.2019.12.011_bib13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.15585\/mmwr.mm6541a5","article-title":"Notes from the field: pediatric emergency department visits for buprenorphine\/naloxone ingestion\u2013United States, 2008-2015","volume":"65","author":"Budnitz","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.011_bib14","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1542\/peds.2007-1774","article-title":"Toxicity of buprenorphine overdoses in children","volume":"121","author":"Hayes","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.011_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1521-0391.2009.00002.x","article-title":"Methadone and buprenorphine toxicity in children","volume":"19","author":"Boyer","year":"2010","journal-title":"Am J Addict"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.011_bib16","doi-asserted-by":"crossref","first-page":"e20163382","DOI":"10.1542\/peds.2016-3382","article-title":"Prescription opioid exposures among children and adolescents in the United States: 2000-2015","volume":"139","author":"Allen","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.011_bib17","doi-asserted-by":"crossref","first-page":"e20173652","DOI":"10.1542\/peds.2017-3652","article-title":"Buprenorphine exposures among children and adolescents reported to US poison control centers","volume":"142","author":"Post","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.011_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.annemergmed.2011.08.004","article-title":"Using poison center data for national public health surveillance for chemical and poison exposure and associated illness","volume":"59","author":"Wolkin","year":"2012","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.annepidem.2019.12.011_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jamia.2010.004317","article-title":"Can poison control data be used for pharmaceutical poisoning surveillance?","volume":"18","author":"Naun","year":"2011","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.annepidem.2019.12.011_bib21","series-title":"National Poison Data System Coding Users' Manual\u00a9","first-page":"67","year":"2014"},{"key":"10.1016\/j.annepidem.2019.12.011_bib22","series-title":"National Poison Data System (NPDS) Data Dictionary","first-page":"24","year":"2012"},{"issue":"10","key":"10.1016\/j.annepidem.2019.12.011_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1080\/15563650.2016.1245421","article-title":"2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report","volume":"54","author":"Mowry","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annepidem.2019.12.011_bib24","author":"Aitken"},{"key":"10.1016\/j.annepidem.2019.12.011_bib25","doi-asserted-by":"crossref","first-page":"e6272","DOI":"10.7717\/peerj.6272","article-title":"Opioid distribution trends (2006-2017) in the US territories","volume":"7","author":"Cabrera","year":"2019","journal-title":"PeerJ"},{"issue":"12","key":"10.1016\/j.annepidem.2019.12.011_bib26","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/add.14378","article-title":"Trends and characteristics of naloxone therapy reported to US poison centers","volume":"113","author":"Rege","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.annepidem.2019.12.011_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jpeds.2018.10.047","article-title":"Prevalence and characteristics of pediatric opioid exposures and poisonings in the United States","volume":"206","author":"Patel","year":"2019","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.annepidem.2019.12.011_bib28","series-title":"Buprenorphine prescribing practices and exposures reported to a poison center\u2014Utah, 2002\u20132011","year":"2012"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.011_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/18744737112059990010","article-title":"Buprenorphine and buprenorphine\/naloxone intoxication in children\u2013how strong is the risk?","volume":"6","author":"Soyka","year":"2013","journal-title":"Curr Drug Abuse Rev"},{"issue":"4","key":"10.1016\/j.annepidem.2019.12.011_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/MLR.0000000000000703","article-title":"Impact of Medicaid expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment","volume":"55","author":"Wen","year":"2017","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.011_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ajad.12174","article-title":"Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013","volume":"24","author":"Turner","year":"2015","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.annepidem.2019.12.011_bib33","first-page":"315","article-title":"A\u00a0review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J\u00a0Addict Med"},{"issue":"7","key":"10.1016\/j.annepidem.2019.12.011_bib34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/archdischild-2015-309921","article-title":"Severe and fatal pharmaceutical poisoning in young children in the UK","volume":"101","author":"Anderson","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.annepidem.2019.12.011_bib35","author":"Dart"},{"issue":"3","key":"10.1016\/j.annepidem.2019.12.011_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2011.09.029","article-title":"Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids","volume":"122","author":"Daniulaityte","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.annepidem.2019.12.011_bib37","first-page":"462","article-title":"Keeping patients safe from methadone overdoses","volume":"36","author":"Grissinger","year":"2011","journal-title":"P\u00a0T"},{"issue":"26","key":"10.1016\/j.annepidem.2019.12.011_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.15585\/mmwr.mm6526a2","article-title":"Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths\u2013United States, 2002-2014","volume":"65","author":"Jones","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.011_bib39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15563650.2016.1244337","article-title":"Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center","volume":"55","author":"Toce","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"10.1016\/j.annepidem.2019.12.011_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/injuryprev-2011-040008","article-title":"Unintentional paediatric ingestion poisonings and the role of imitative behaviour","volume":"18","author":"Rodgers","year":"2012","journal-title":"Inj Prev"},{"issue":"1\u20133","key":"10.1016\/j.annepidem.2019.12.011_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.drugalcdep.2008.07.017","article-title":"Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence","volume":"99","author":"Lavie","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.annepidem.2019.12.011_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1521-0391.2009.00008.x","article-title":"Indicators of buprenorphine and methadone use and abuse: what do we know?","volume":"19","author":"Maxwell","year":"2010","journal-title":"Am J Addict"},{"issue":"12","key":"10.1016\/j.annepidem.2019.12.011_bib44","doi-asserted-by":"crossref","first-page":"320","DOI":"10.15585\/mmwr.mm6612a2","article-title":"Methadone prescribing and overdose and the association with Medicaid preferred drug list policies - United States, 2007-2014","volume":"66","author":"Faul","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.annepidem.2019.12.011_bib45","first-page":"988","article-title":"Geographic variation in opioid prescribing in the U.S","volume":"13","author":"McDonald","year":"2012","journal-title":"J\u00a0Pain"},{"issue":"11","key":"10.1016\/j.annepidem.2019.12.011_bib46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.mlr.0000228025.04535.25","article-title":"Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002","volume":"44","author":"Zerzan","year":"2006","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.annepidem.2019.12.011_bib47","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15563650701233370","article-title":"Understanding the limitations of retrospective analyses of poison center data","volume":"45","author":"Hoffman","year":"2007","journal-title":"Clin Toxicol (Phila)"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279718310147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279718310147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:24:50Z","timestamp":1760927090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279718310147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":42,"alternative-id":["S1047279718310147"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2019.12.011","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of pediatric buprenorphine and methadone exposures reported to the poison centers","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2019.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}